SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2qn0'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FK6_A_LNLA1201_1
(NON-SPECIFIC LIPID
TRANSFER PROTEIN)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 LEU A 231
ASN A 232
ILE A 226
TYR A 367
ILE A 224
 None
 0.96A 1fk6A-2qn0A:
undetectable		 1fk6A-2qn0A:
10.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I9G_A_SAMA301_1
(HYPOTHETICAL PROTEIN
RV2118C)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		3 / 3 GLU A 230
HIS A 233
ASP A 167
 ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
None
 0.81A 1i9gA-2qn0A:
undetectable		 1i9gA-2qn0A:
18.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_A_LPRA801_1
(ANGIOTENSIN
CONVERTING ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 1.01A 1j36A-2qn0A:
2.1		 1j36A-2qn0A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_B_LPRB802_1
(ANGIOTENSIN
CONVERTING ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 1.02A 1j36B-2qn0A:
2.2		 1j36B-2qn0A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J37_A_X8ZA801_1
(ANGIOTENSIN
CONVERTING ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 11 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 0.99A 1j37A-2qn0A:
2.4		 1j37A-2qn0A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J37_B_X8ZB802_1
(ANGIOTENSIN
CONVERTING ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 11 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 0.99A 1j37B-2qn0A:
2.3		 1j37B-2qn0A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KI7_A_ID2A1_0
(THYMIDINE KINASE)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 ILE A 241
TYR A 351
ALA A 268
TYR A 271
GLU A 290
 None
 1.40A 1ki7A-2qn0A:
undetectable		 1ki7A-2qn0A:
19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1O86_A_LPRA702_1
(ANGIOTENSIN
CONVERTING ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 0.97A 1o86A-2qn0A:
2.4		 1o86A-2qn0A:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_G_BEZG513_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 5 ARG A 372
ILE A 194
PRO A 168
GLU A 230
 None
None
None
ZN  A 431 ( 4.0A)
 1.42A 1oniG-2qn0A:
undetectable
1oniH-2qn0A:
undetectable		 1oniG-2qn0A:
16.62
1oniH-2qn0A:
16.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_A_PNXA1435_1
(CHITINASE)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 6 TYR A 322
GLY A  41
SER A 111
ARG A  38
 None
 1.22A 2a3cA-2qn0A:
undetectable		 2a3cA-2qn0A:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_B_PNXB2434_1
(CHITINASE)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 6 TYR A 322
GLY A  41
SER A 111
ARG A  38
 None
 1.29A 2a3cB-2qn0A:
undetectable		 2a3cB-2qn0A:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AZX_A_TRPA602_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 8 LEU A 280
ILE A 249
LEU A 376
ILE A 374
 None
 0.87A 2azxA-2qn0A:
undetectable		 2azxA-2qn0A:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BM9_D_SAMD301_1
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		3 / 3 ASP A 394
ASP A 389
ASN A 400
 None
 0.84A 2bm9D-2qn0A:
undetectable		 2bm9D-2qn0A:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_A_LPRA705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 0.96A 2c6nA-2qn0A:
2.8		 2c6nA-2qn0A:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_B_LPRB705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 1.03A 2c6nB-2qn0A:
undetectable		 2c6nB-2qn0A:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_B_LPRB705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
LYS A  68
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
None
None
 1.41A 2c6nB-2qn0A:
undetectable		 2c6nB-2qn0A:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VCT_D_ASDD1223_1
(GLUTATHIONE
S-TRANSFERASE A2)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 7 TYR A 367
ILE A 102
GLY A 103
LEU A 110
 None
 1.01A 2vctD-2qn0A:
undetectable		 2vctD-2qn0A:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X8Z_A_X8ZA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 11 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 0.94A 2x8zA-2qn0A:
2.0		 2x8zA-2qn0A:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X8Z_A_X8ZA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 11 HIS A 229
GLU A 230
HIS A 233
LYS A  68
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
None
None
 1.42A 2x8zA-2qn0A:
2.0		 2x8zA-2qn0A:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X91_A_LPRA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 0.96A 2x91A-2qn0A:
undetectable		 2x91A-2qn0A:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X91_A_LPRA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
LYS A  68
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
None
None
 1.40A 2x91A-2qn0A:
undetectable		 2x91A-2qn0A:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YGP_A_PCFA1213_1
(WNT INHIBITORY
FACTOR 1)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 9 ILE A 226
ILE A 194
PHE A  86
ILE A  97
VAL A 136
 None
 1.41A 2ygpA-2qn0A:
0.0		 2ygpA-2qn0A:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KEC_B_HAEB271_1
(COLLAGENASE 3)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		3 / 3 HIS A 229
GLU A 230
HIS A 233
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
 0.16A 3kecB-2qn0A:
undetectable		 3kecB-2qn0A:
15.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RAV_A_RAVA183_1
(FERRITIN LIGHT CHAIN)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 6 LEU A 388
TYR A 393
ALA A 385
ARG A 197
 None
 0.89A 3ravA-2qn0A:
undetectable		 3ravA-2qn0A:
15.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_A_ZPCA1318_2
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 7 TYR A 202
VAL A 379
ILE A 256
GLU A 360
 None
 0.88A 4a97E-2qn0A:
undetectable		 4a97E-2qn0A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_D_ZPCD1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 8 TYR A 202
VAL A 379
ILE A 256
GLU A 360
 None
 0.89A 4a97C-2qn0A:
undetectable		 4a97C-2qn0A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_E_ZPCE1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 8 TYR A 202
VAL A 379
ILE A 256
GLU A 360
 None
 1.01A 4a97D-2qn0A:
undetectable		 4a97D-2qn0A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_H_ZPCH1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 8 TYR A 202
VAL A 379
ILE A 256
GLU A 360
 None
 0.92A 4a97G-2qn0A:
undetectable		 4a97G-2qn0A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_I_ZPCI1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 7 TYR A 202
VAL A 379
ILE A 256
GLU A 360
 None
 0.97A 4a97H-2qn0A:
undetectable		 4a97H-2qn0A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_J_ZPCJ1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 8 TYR A 202
VAL A 379
ILE A 256
GLU A 360
 None
 0.90A 4a97I-2qn0A:
undetectable		 4a97I-2qn0A:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C2P_A_X8ZA709_1
(ANGIOTENSIN-CONVERTI
NG ENZYME)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 11 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 0.98A 4c2pA-2qn0A:
2.4		 4c2pA-2qn0A:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F4D_A_CHDA505_0
(FERROCHELATASE,
MITOCHONDRIAL)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 7 MET A 199
ILE A 387
ARG A  96
VAL A 369
 None
 1.28A 4f4dA-2qn0A:
undetectable		 4f4dA-2qn0A:
23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OR0_A_NPSA603_1
(SERUM ALBUMIN)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 11 LEU A 110
SER A 190
LEU A 189
LEU A 231
LEU A 238
 None
 1.15A 4or0A-2qn0A:
undetectable		 4or0A-2qn0A:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R7L_A_SHHA709_1
(LEUKOTRIENE A-4
HYDROLASE)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 12 HIS A 229
GLU A 230
HIS A 233
GLU A 269
TYR A 375
 ZN  A 431 (-3.3A)
ZN  A 431 ( 4.0A)
ZN  A 431 (-3.3A)
ZN  A 431 (-2.1A)
None
 0.45A 4r7lA-2qn0A:
3.0		 4r7lA-2qn0A:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCK_B_SAMB2409_1
(RNA-DIRECTED RNA
POLYMERASE L)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 6 SER A 314
GLY A 150
ASP A 130
ASP A  23
 None
 0.99A 4uckB-2qn0A:
undetectable		 4uckB-2qn0A:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W9N_C_CCSC1548_0
(ENOYL-[ACYL-CARRIER-
PROTEIN] REDUCTASE)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		3 / 3 ALA A  36
TRP A  44
VAL A  45
 None
 0.29A 4w9nC-2qn0A:
undetectable		 4w9nC-2qn0A:
19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CXV_A_0HKA501_2
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M1,ENDOLYSIN,MUSCARI
NIC ACETYLCHOLINE
RECEPTOR M1)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		3 / 3 THR A 126
THR A 309
PHE A 315
 None
 0.91A 5cxvA-2qn0A:
undetectable		 5cxvA-2qn0A:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IEN_B_VDYB201_1
(CDL2.2)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		5 / 10 TYR A  76
PRO A 168
ILE A  90
LEU A  93
LEU A  77
 None
 1.19A 5ienB-2qn0A:
undetectable		 5ienB-2qn0A:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L2T_A_6ZZA900_2
(CYCLIN-DEPENDENT
KINASE 6)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		3 / 3 LYS A 329
GLN A 183
ASN A 237
 None
 1.01A 5l2tA-2qn0A:
undetectable		 5l2tA-2qn0A:
22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X2S_I_PEMI202_1
(HEMOGLOBIN SUBUNIT
ALPHA
HEMOGLOBIN SUBUNIT
BETA)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 8 PRO A 223
THR A 384
TYR A 393
PRO A 161
 None
 1.07A 5x2sI-2qn0A:
undetectable
5x2sJ-2qn0A:
undetectable
5x2sK-2qn0A:
undetectable		 5x2sI-2qn0A:
17.42
5x2sJ-2qn0A:
16.22
5x2sK-2qn0A:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CDU_G_EY4G501_0
(CHIMERIC ALPHA1GABAA
RECEPTOR)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 7 ILE A 192
PRO A 196
ILE A  43
THR A  40
 None
 0.92A 6cduF-2qn0A:
undetectable
6cduG-2qn0A:
undetectable		 6cduF-2qn0A:
22.35
6cduG-2qn0A:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MA7_A_TPFA602_0
(CYTOCHROME P450 3A4)		 2qn0 NEUROTOXIN
(Clostridium
botulinum) 		4 / 7 SER A 190
ALA A 182
ILE A 243
ALA A 268
 None
 0.85A 6ma7A-2qn0A:
undetectable		 6ma7A-2qn0A:
11.16